创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

Advanced Search

column
Application of Squalene in Vaccine Adjuvant
LI Chunjiayu, KUANG Xiaoqin, XUE Jiawen, LIU Zhengyu, TU Jiasheng, SUN Chunmeng
2025, 49(2): 81-90. DOI: 10.20053/j.issn1001-5094.2025.02.001
Abstract PDF
Risk Management and Assessment of Elemental Impurities for Pharmaceutical Excipients Based on ICH Guidelines
WANG Suming, SONG Yu, CHEN Lei
2025, 49(2): 91-99. DOI: 10.20053/j.issn1001-5094.2025.02.002
Abstract PDF
Research Status and Challenges of Oxidation Indexes of Lipid-Based Pharmaceutical Excipients
TANG Hao, SUN Yinyin, GAN Yong, GUO Shiyan
2025, 49(2): 100-110. DOI: 10.20053/j.issn1001-5094.2025.02.003
Abstract PDF
Research Progress of Stimuli-Responsive Carriers and Their Materials
ZHANG Xueyan, WANG Jue, WANG Xiaofeng, HE Liuying, WANG Huijuan, YANG Rui, ZHAO Xia, SUN Huimin
2025, 49(2): 111-125. DOI: 10.20053/j.issn1001-5094.2025.02.004
Abstract PDF
Research Progress of Membrane-Associated Tyrosine/Threonine 1 Kinase Inhibitors
YUAN Jianglin, YAN Sida, GAO Mohan, XIE Zhao, WEI Qunchao
2025, 49(2): 126-136. DOI: 10.20053/j.issn1001-5094.2025.02.005
Abstract PDF
Progress of Research on Stimulator of Interferon Genes-Associated Vasculopathy with Onset in Infancy
CHEN Saihua, MAIMAITI Munire, ZHONG Ziwei, HONG Ze, WANG Chen
2025, 49(2): 137-145. DOI: 10.20053/j.issn1001-5094.2025.02.006
Abstract PDF
Research Progress of Apoptosis Signal Regulating Kinase 1 Inhibitors
BAI Chen, WANG Xiaoyu, XING Junhao
2025, 49(2): 146-155. DOI: 10.20053/j.issn1001-5094.2025.02.007
Abstract PDF
Analysis of Policies on Integrated Traditional Chinese and Western Medicine in China in the “Healthy China” Context
LIU Ruoying, LAN Yafei, NA Xin, CHU Shuzhen
2025, 49(2): 156-附页4. DOI: 10.20053/j.issn1001-5094.2025.02.008
Abstract PDF